IR

Iyona Rajkomar

Managing Partner, Dawn Biopharma

Greater London, England

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

London

  • Min Investment:

    $10,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Management Consulting
Pharmaceutical Industry
Equity Research
Due Diligence
Business Transformation
Business Planning
Market Analysis
Market Research

Education

Lists including Iyona

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Adcytherix

Seed

Total Funding: $32M

ADCendo

Series A

Total Funding: $110M

AgomAb Therapeutics

Series C

Total Funding: $200M

Amolyt Pharma

Series B

Total Funding: $290M

Antios Therapeutics

Series B

Total Funding: $200M

Abcuro

Series A

Total Funding: $42M

Work Experience

DB
Dawn Biopharma

2023

  • Managing Partner

    2023

PV
Pontifax Venture Capital

2019 - 2023

  • Partner

    2019 - 2023

AL
Advent Life Sciences LLP

2015 - 2019

  • Principal

    2017 - 2019

  • Associate

    2015 - 2017

IV
Inventages Venture Capital

2014 - 2015

  • Investment Manager

    2014 - 2015

P
PwC

2011 - 2014

  • Strategy Consultant, Pharmaceuticals and Lifesciences

    2011 - 2014

    Areas of expertise - Strategic options development and analysis; - Business analysis and planning; - Strategic business development; - Commercial due diligence; - Market research, analysis and forecasting; - Project and programme management.

BG
Bryan Garnier & Co

2009 - 2010

  • Equity Research Analyst

    2009 - 2010

    European pharma

U
UBS

2007 - 2009

  • Equity Research Analyst

    2007 - 2009

    Large cap European pharmaceuticals

SG
St Georges Healthcare NHS Trust

2006 - 2007

  • Medical Doctor

    2006 - 2007